Insiders · GTBP

GTBP insider transactions

GT Biopharma Inc. (GTBP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for GTBP

• 274d
  SEC Form 4 filed by Director Mun-Gavin David C.

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 274d
  SEC Form 4 filed by CEO and Director Breen Michael Martin

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 274d
  SEC Form 4 filed by Director Casamento Charles J

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 274d
  SEC Form 4 filed by Chief Financial Officer Urban Alan Louis

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 274d
  SEC Form 4 filed by Director Kramer Hilary

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 314d
  SEC Form 3 filed by new insider Mun-Gavin David C.

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 371d
  SEC Form 3 filed by new insider Kramer Hilary

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 376d
  SEC Form 3 filed by new insider Ritter Andrew J

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 596d
  SEC Form 4 filed by Chief Financial Officer Urban Alan Louis

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 726d
  SEC Form 3 filed by new insider Urban Alan Louis

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1029d
  SEC Form 4: Breen Michael Martin was granted 200,000 shares, increasing direct ownership by 30% to 856,218 units

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1029d
  SEC Form 4: Ohri Manu acquired $57,400 worth of shares (200,000 units at $0.29), was granted 200,000 shares and disposed of $57,400 worth of shares (200,000 units at $0.29)

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1084d
  SEC Form 4 filed by Casamento Charles J

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1132d
  SEC Form 3 filed by new insider Casamento Charles J

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1155d
  SEC Form 4 filed by Breen Michael Martin

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1156d
  SEC Form 4 filed by Ohri Manu

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1224d
  SEC Form 4 filed by Shrotriya Rajesh C Md

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1224d
  SEC Form 4 filed by Breen Michael Martin

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1224d
  SEC Form 4 filed by Ohri Manu

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1224d
  SEC Form 4 filed by Wendel Bruce

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1421d
  SEC Form 4: Breen Michael Martin was granted 278,058 shares, increasing direct ownership by 85% to 606,218 units

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1421d
  SEC Form 4 filed by Shrotriya Rajesh C Md

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1421d
  SEC Form 4 filed by Urban Alan Louis

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1421d
  SEC Form 4 filed by Berk Gregory

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1421d
  SEC Form 4: Ohri Manu was granted 100,000 shares, disposed of 100,000 shares and acquired 100,000 shares

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1421d
  SEC Form 4 filed by Wendel Bruce

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1456d
  SEC Form 3 filed by new insider Urban Alan Louis

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1572d
  SEC Form 3 filed by new insider Ohri Manu

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1576d
  SEC Form 4 filed by Choy Gavin

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1576d
  SEC Form 3 filed by new insider Choy Gavin

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1576d
  SEC Form 3 filed by new insider Shrotriya Rajesh C Md

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1670d
  SEC Form 4: Breen Michael Martin converted options into 50,102 shares and was granted 278,058 shares

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1670d
  SEC Form 3 filed by new insider Breen Michael Martin

  3 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1706d
  SEC Form 4: Wendel Bruce bought $26,299 worth of shares (5,083 units at $5.17) and was granted 347,572 shares

  4 - GT Biopharma, Inc. (0000109657) (Issuer)
• 1706d
  SEC Form 3 filed by new insider Wendel Bruce

  3 - GT Biopharma, Inc. (0000109657) (Issuer)